AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues.
AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.
-
+41 61 515 07 70
-
Dr. Werner Tschollar
